Atlanpole Biotherapies
  • enfr
  • Atlanpole Biotherapies
    • About us
    • Approaches to excellence
      • Biotech / Pharma
      • MedTech
      • Digital Health
      • Disease Prevention
    • Team
    • Board of Directors
    • Funding
  • Our network
    • Members
    • Partners
    • European network
  • News & Events
    • Events
    • News
  • Services
    • Diversify your network
    • Broaden your horizons
    • Develop your innovation projects
    • Enhance your public profile
  • Contact
News

mcsaf

      Home > The European Patent Office has granted McSAF a patent for DAR 4 antibody-drug conjugates technology > mcsaf
1 March 2021

All news
  • Linkedin
  • Mail
< Previous post
Back to list

Biotech / Pharma

MedTech

Digital Health

Disease Prevention

  • Legal Statement
  • Privacy policy for personal data
  • Events
  • News

Find us

  • Mail